Previous studies indicated that kidney cancer is one of those cancers showing a relative low frequency of TERT promoter hotspot mutations 46-48, while both our tissue microarray data and TCGA data demonstrated that there was significantly higher expression of mRNA and protein of TERT in tumor tissues relative to normal tissues. This evidence concerns the gene TERT and kidney cancer.